Physician profile
Christopher Suhre
NPI 1255350252
$968.65
in general payments reported to CMS, 2019-2025
20 companies · $248 in 2025
The $248 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $57.94 · 2021: $146 · 2022: $53.22 · 2023: $167 · 2024: $190 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $205.84 | 2019-2025 | Bexsero, Pediarix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $103.53 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $85.19 | 2023-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $74.99 | 2021-2024 | Qelbree |
| Pfizer INC. | $66.66 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $65.50 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $60.07 | 2022-2024 | |
| Xeris Pharmaceuticals, INC. | $59.66 | 2025 | Keveyis, Gvoke Hypopen |
| Cranial Technologies, INC | $38.77 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $36.40 | 2019-2023 | |
| Lilly USA, LLC | $29.83 | 2023 | Emgality, Baqsimi, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.76 | 2025 | Caplyta |
| Seqirus USA INC | $20.52 | 2025 | Flucelvax |
| Abbvie INC. | $15.16 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.70 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $14.41 | 2025 | Apretude |
| Exact Sciences Corporation | $13.79 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.64 | 2024 | Spravato |
| Abbott Laboratories | $13.52 | 2023 | Freestyle Libre 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Suhre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.